投稿についてもっと詳しく Cilcare Doubles Down on Hearing Loss: Updates License Deal with Sanofi who becomes equity holder
Cilcare Doubles Down on Hearing Loss: Updates License Deal with Sanofi who becomes equity holder

Cilcare Doubles Down on Hearing Loss: Updates License Deal with Sanofi who becomes equity holder

Montpellier, France, Paris, France and Boston, USA - June 23, 2026 - Cilcare, a biotechnology company focused on developing novel therapies for hearing disorders, announces an update of its license…

続きを読むCilcare Doubles Down on Hearing Loss: Updates License Deal with Sanofi who becomes equity holder